M-CAP Technologies International – Trademark Portfolio

Entity Type: 02

M-CAP Technologies International holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 4 Nice Classification classes. The owner is based in Wilmington, DE.

3411 Silverside Road, Quillen Building

Wilmington, DE 19810

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

M-CAP Technologies International's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (2 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

37
Building & Construction (1 filing)

Building construction; repair; installation services

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does M-CAP Technologies International have?

M-CAP Technologies International has 6 U.S. trademarks filed with the USPTO.

What trademark classes does M-CAP Technologies International file in?

M-CAP Technologies International files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 37 (Building & Construction), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is M-CAP Technologies International's trademark registration success rate?

M-CAP Technologies International has a 0% trademark registration rate, with 0 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.